Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Precision Cancer Diagnostic Tests
1.2 Key Market Segments
1.2.1 Precision Cancer Diagnostic Tests Segment by Type
1.2.2 Precision Cancer Diagnostic Tests Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Precision Cancer Diagnostic Tests Market Overview
2.1 Global Market Overview
2.1.1 Global Precision Cancer Diagnostic Tests Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Precision Cancer Diagnostic Tests Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Precision Cancer Diagnostic Tests Market Competitive Landscape
3.1 Global Precision Cancer Diagnostic Tests Sales by Manufacturers (2019-2024)
3.2 Global Precision Cancer Diagnostic Tests Revenue Market Share by Manufacturers (2019-2024)
3.3 Precision Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Precision Cancer Diagnostic Tests Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Precision Cancer Diagnostic Tests Sales Sites, Area Served, Product Type
3.6 Precision Cancer Diagnostic Tests Market Competitive Situation and Trends
3.6.1 Precision Cancer Diagnostic Tests Market Concentration Rate
3.6.2 Global 5 and 10 Largest Precision Cancer Diagnostic Tests Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Precision Cancer Diagnostic Tests Industry Chain Analysis
4.1 Precision Cancer Diagnostic Tests Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Precision Cancer Diagnostic Tests Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Precision Cancer Diagnostic Tests Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Precision Cancer Diagnostic Tests Sales Market Share by Type (2019-2024)
6.3 Global Precision Cancer Diagnostic Tests Market Size Market Share by Type (2019-2024)
6.4 Global Precision Cancer Diagnostic Tests Price by Type (2019-2024)
7 Precision Cancer Diagnostic Tests Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Precision Cancer Diagnostic Tests Market Sales by Application (2019-2024)
7.3 Global Precision Cancer Diagnostic Tests Market Size (M USD) by Application (2019-2024)
7.4 Global Precision Cancer Diagnostic Tests Sales Growth Rate by Application (2019-2024)
8 Precision Cancer Diagnostic Tests Market Segmentation by Region
8.1 Global Precision Cancer Diagnostic Tests Sales by Region
8.1.1 Global Precision Cancer Diagnostic Tests Sales by Region
8.1.2 Global Precision Cancer Diagnostic Tests Sales Market Share by Region
8.2 North America
8.2.1 North America Precision Cancer Diagnostic Tests Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Precision Cancer Diagnostic Tests Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Precision Cancer Diagnostic Tests Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Precision Cancer Diagnostic Tests Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Precision Cancer Diagnostic Tests Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Abbott Laboratories
9.1.1 Abbott Laboratories Precision Cancer Diagnostic Tests Basic Information
9.1.2 Abbott Laboratories Precision Cancer Diagnostic Tests Product Overview
9.1.3 Abbott Laboratories Precision Cancer Diagnostic Tests Product Market Performance
9.1.4 Abbott Laboratories Business Overview
9.1.5 Abbott Laboratories Precision Cancer Diagnostic Tests SWOT Analysis
9.1.6 Abbott Laboratories Recent Developments
9.2 Agilent Technologies
9.2.1 Agilent Technologies Precision Cancer Diagnostic Tests Basic Information
9.2.2 Agilent Technologies Precision Cancer Diagnostic Tests Product Overview
9.2.3 Agilent Technologies Precision Cancer Diagnostic Tests Product Market Performance
9.2.4 Agilent Technologies Business Overview
9.2.5 Agilent Technologies Precision Cancer Diagnostic Tests SWOT Analysis
9.2.6 Agilent Technologies Recent Developments
9.3 Becton Dickinson and Company
9.3.1 Becton Dickinson and Company Precision Cancer Diagnostic Tests Basic Information
9.3.2 Becton Dickinson and Company Precision Cancer Diagnostic Tests Product Overview
9.3.3 Becton Dickinson and Company Precision Cancer Diagnostic Tests Product Market Performance
9.3.4 Becton Dickinson and Company Precision Cancer Diagnostic Tests SWOT Analysis
9.3.5 Becton Dickinson and Company Business Overview
9.3.6 Becton Dickinson and Company Recent Developments
9.4 Bio-Rad Laboratories
9.4.1 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Basic Information
9.4.2 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Product Overview
9.4.3 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Product Market Performance
9.4.4 Bio-Rad Laboratories Business Overview
9.4.5 Bio-Rad Laboratories Recent Developments
9.5 Biocartis N.V.
9.5.1 Biocartis N.V. Precision Cancer Diagnostic Tests Basic Information
9.5.2 Biocartis N.V. Precision Cancer Diagnostic Tests Product Overview
9.5.3 Biocartis N.V. Precision Cancer Diagnostic Tests Product Market Performance
9.5.4 Biocartis N.V. Business Overview
9.5.5 Biocartis N.V. Recent Developments
9.6 Biocept
9.6.1 Biocept Precision Cancer Diagnostic Tests Basic Information
9.6.2 Biocept Precision Cancer Diagnostic Tests Product Overview
9.6.3 Biocept Precision Cancer Diagnostic Tests Product Market Performance
9.6.4 Biocept Business Overview
9.6.5 Biocept Recent Developments
9.7 bioMerieux SA
9.7.1 bioMerieux SA Precision Cancer Diagnostic Tests Basic Information
9.7.2 bioMerieux SA Precision Cancer Diagnostic Tests Product Overview
9.7.3 bioMerieux SA Precision Cancer Diagnostic Tests Product Market Performance
9.7.4 bioMerieux SA Business Overview
9.7.5 bioMerieux SA Recent Developments
9.8 Canon Medical Systems Corporation
9.8.1 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Basic Information
9.8.2 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Product Overview
9.8.3 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Product Market Performance
9.8.4 Canon Medical Systems Corporation Business Overview
9.8.5 Canon Medical Systems Corporation Recent Developments
9.9 Cynvenio Biosystems
9.9.1 Cynvenio Biosystems Precision Cancer Diagnostic Tests Basic Information
9.9.2 Cynvenio Biosystems Precision Cancer Diagnostic Tests Product Overview
9.9.3 Cynvenio Biosystems Precision Cancer Diagnostic Tests Product Market Performance
9.9.4 Cynvenio Biosystems Business Overview
9.9.5 Cynvenio Biosystems Recent Developments
9.10 Danaher Corporation
9.10.1 Danaher Corporation Precision Cancer Diagnostic Tests Basic Information
9.10.2 Danaher Corporation Precision Cancer Diagnostic Tests Product Overview
9.10.3 Danaher Corporation Precision Cancer Diagnostic Tests Product Market Performance
9.10.4 Danaher Corporation Business Overview
9.10.5 Danaher Corporation Recent Developments
9.11 Epigenomics AG
9.11.1 Epigenomics AG Precision Cancer Diagnostic Tests Basic Information
9.11.2 Epigenomics AG Precision Cancer Diagnostic Tests Product Overview
9.11.3 Epigenomics AG Precision Cancer Diagnostic Tests Product Market Performance
9.11.4 Epigenomics AG Business Overview
9.11.5 Epigenomics AG Recent Developments
9.12 Exosome Diagnostics
9.12.1 Exosome Diagnostics Precision Cancer Diagnostic Tests Basic Information
9.12.2 Exosome Diagnostics Precision Cancer Diagnostic Tests Product Overview
9.12.3 Exosome Diagnostics Precision Cancer Diagnostic Tests Product Market Performance
9.12.4 Exosome Diagnostics Business Overview
9.12.5 Exosome Diagnostics Recent Developments
9.13 Foundation Medicine
9.13.1 Foundation Medicine Precision Cancer Diagnostic Tests Basic Information
9.13.2 Foundation Medicine Precision Cancer Diagnostic Tests Product Overview
9.13.3 Foundation Medicine Precision Cancer Diagnostic Tests Product Market Performance
9.13.4 Foundation Medicine Business Overview
9.13.5 Foundation Medicine Recent Developments
9.14 General Electric Company
9.14.1 General Electric Company Precision Cancer Diagnostic Tests Basic Information
9.14.2 General Electric Company Precision Cancer Diagnostic Tests Product Overview
9.14.3 General Electric Company Precision Cancer Diagnostic Tests Product Market Performance
9.14.4 General Electric Company Business Overview
9.14.5 General Electric Company Recent Developments
9.15 Genomic Health
9.15.1 Genomic Health Precision Cancer Diagnostic Tests Basic Information
9.15.2 Genomic Health Precision Cancer Diagnostic Tests Product Overview
9.15.3 Genomic Health Precision Cancer Diagnostic Tests Product Market Performance
9.15.4 Genomic Health Business Overview
9.15.5 Genomic Health Recent Developments
9.16 Hologic
9.16.1 Hologic Precision Cancer Diagnostic Tests Basic Information
9.16.2 Hologic Precision Cancer Diagnostic Tests Product Overview
9.16.3 Hologic Precision Cancer Diagnostic Tests Product Market Performance
9.16.4 Hologic Business Overview
9.16.5 Hologic Recent Developments
9.17 Illumina
9.17.1 Illumina Precision Cancer Diagnostic Tests Basic Information
9.17.2 Illumina Precision Cancer Diagnostic Tests Product Overview
9.17.3 Illumina Precision Cancer Diagnostic Tests Product Market Performance
9.17.4 Illumina Business Overview
9.17.5 Illumina Recent Developments
9.18 Menarini Silicon Biosystems SpA
9.18.1 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Basic Information
9.18.2 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Product Overview
9.18.3 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Product Market Performance
9.18.4 Menarini Silicon Biosystems SpA Business Overview
9.18.5 Menarini Silicon Biosystems SpA Recent Developments
9.19 Myriad Genetics
9.19.1 Myriad Genetics Precision Cancer Diagnostic Tests Basic Information
9.19.2 Myriad Genetics Precision Cancer Diagnostic Tests Product Overview
9.19.3 Myriad Genetics Precision Cancer Diagnostic Tests Product Market Performance
9.19.4 Myriad Genetics Business Overview
9.19.5 Myriad Genetics Recent Developments
9.20 NanoString Technologies
9.20.1 NanoString Technologies Precision Cancer Diagnostic Tests Basic Information
9.20.2 NanoString Technologies Precision Cancer Diagnostic Tests Product Overview
9.20.3 NanoString Technologies Precision Cancer Diagnostic Tests Product Market Performance
9.20.4 NanoString Technologies Business Overview
9.20.5 NanoString Technologies Recent Developments
9.21 Ortho Clinical Diagnostics
9.21.1 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Basic Information
9.21.2 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Product Overview
9.21.3 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Product Market Performance
9.21.4 Ortho Clinical Diagnostics Business Overview
9.21.5 Ortho Clinical Diagnostics Recent Developments
9.22 QIAGEN N.V.
9.22.1 QIAGEN N.V. Precision Cancer Diagnostic Tests Basic Information
9.22.2 QIAGEN N.V. Precision Cancer Diagnostic Tests Product Overview
9.22.3 QIAGEN N.V. Precision Cancer Diagnostic Tests Product Market Performance
9.22.4 QIAGEN N.V. Business Overview
9.22.5 QIAGEN N.V. Recent Developments
9.23 Randox Laboratories Ltd.
9.23.1 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Basic Information
9.23.2 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Product Overview
9.23.3 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Product Market Performance
9.23.4 Randox Laboratories Ltd. Business Overview
9.23.5 Randox Laboratories Ltd. Recent Developments
9.24 Roche Holding AG
9.24.1 Roche Holding AG Precision Cancer Diagnostic Tests Basic Information
9.24.2 Roche Holding AG Precision Cancer Diagnostic Tests Product Overview
9.24.3 Roche Holding AG Precision Cancer Diagnostic Tests Product Market Performance
9.24.4 Roche Holding AG Business Overview
9.24.5 Roche Holding AG Recent Developments
9.25 Royal Philips N.V.
9.25.1 Royal Philips N.V. Precision Cancer Diagnostic Tests Basic Information
9.25.2 Royal Philips N.V. Precision Cancer Diagnostic Tests Product Overview
9.25.3 Royal Philips N.V. Precision Cancer Diagnostic Tests Product Market Performance
9.25.4 Royal Philips N.V. Business Overview
9.25.5 Royal Philips N.V. Recent Developments
9.26 Siemens AG
9.26.1 Siemens AG Precision Cancer Diagnostic Tests Basic Information
9.26.2 Siemens AG Precision Cancer Diagnostic Tests Product Overview
9.26.3 Siemens AG Precision Cancer Diagnostic Tests Product Market Performance
9.26.4 Siemens AG Business Overview
9.26.5 Siemens AG Recent Developments
9.27 Thermo Fisher Scientific
9.27.1 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Basic Information
9.27.2 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Product Overview
9.27.3 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Product Market Performance
9.27.4 Thermo Fisher Scientific Business Overview
9.27.5 Thermo Fisher Scientific Recent Developments
9.28 Vela Diagnostics
9.28.1 Vela Diagnostics Precision Cancer Diagnostic Tests Basic Information
9.28.2 Vela Diagnostics Precision Cancer Diagnostic Tests Product Overview
9.28.3 Vela Diagnostics Precision Cancer Diagnostic Tests Product Market Performance
9.28.4 Vela Diagnostics Business Overview
9.28.5 Vela Diagnostics Recent Developments
10 Precision Cancer Diagnostic Tests Market Forecast by Region
10.1 Global Precision Cancer Diagnostic Tests Market Size Forecast
10.2 Global Precision Cancer Diagnostic Tests Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Precision Cancer Diagnostic Tests Market Size Forecast by Country
10.2.3 Asia Pacific Precision Cancer Diagnostic Tests Market Size Forecast by Region
10.2.4 South America Precision Cancer Diagnostic Tests Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Precision Cancer Diagnostic Tests by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Precision Cancer Diagnostic Tests Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Precision Cancer Diagnostic Tests by Type (2025-2030)
11.1.2 Global Precision Cancer Diagnostic Tests Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Precision Cancer Diagnostic Tests by Type (2025-2030)
11.2 Global Precision Cancer Diagnostic Tests Market Forecast by Application (2025-2030)
11.2.1 Global Precision Cancer Diagnostic Tests Sales (K Units) Forecast by Application
11.2.2 Global Precision Cancer Diagnostic Tests Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
